Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 224,572 | 386,653 | 514,177 | 432,978 | 219,544 |
| Marketable Securities | 325,897 | 385,014 | 457,359 | 655,846 | 884,497 |
| TOTAL | $569,465 | $790,920 | $990,435 | $1,121,605 | $1,139,307 |
| Non-Current Assets | |||||
| PPE Net | 19,125 | 19,558 | 20,388 | 21,129 | 22,090 |
| Investments And Advances | 160,796 | 52,953 | 34,419 | 0 | 0 |
| Other Non-Current Assets | 35,319 | 37,596 | 39,417 | 41,202 | 29,323 |
| TOTAL | $215,240 | $110,107 | $94,224 | $62,331 | $51,413 |
| Total Assets | $784,705 | $901,027 | $1,084,659 | $1,183,936 | $1,190,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 32,135 | 30,037 | 23,417 | 21,980 | 35,351 |
| Accrued Expenses | 29,129 | 18,434 | 36,701 | 20,969 | 18,325 |
| TOTAL | $66,316 | $53,355 | $64,837 | $47,507 | $58,077 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 8,993 | 9,466 | 9,962 | 10,410 | 10,963 |
| TOTAL | $45,152 | $46,951 | $48,742 | $50,437 | $52,174 |
| Total Liabilities | $111,468 | $100,306 | $113,579 | $97,944 | $110,251 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 61,659 | 61,328 | 61,074 | 60,696 | 60,335 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | -2,124,164 | -1,968,555 | -1,772,243 | -1,626,148 | -1,507,731 |
| Other shareholders' equity | -280 | 122 | 92 | 204 | 700 |
| TOTAL | $673,237 | $800,721 | $971,080 | $1,085,992 | $1,080,469 |
| Total Liabilities And Equity | $784,705 | $901,027 | $1,084,659 | $1,183,936 | $1,190,720 |